Massive Bio has joined NVIDIA Inception, an innovative program designed to support startups transforming industries through advanced technology.
Massive Bio specializes in leveraging artificial intelligence to optimize patient identification and enrollment for oncology clinical trials. Our AI-driven platform accelerates trial recruitment, enabling biopharma companies to efficiently connect patients worldwide to suitable clinical studies.
Joining NVIDIA Inception empowers Massive Bio to further enhance our AI capabilities, scale our technology platform, and accelerate growth through NVIDIA’s extensive go-to-market support, technical expertise, and targeted training resources. Additionally, this collaboration offers opportunities for Massive Bio to partner with top industry experts and innovative AI-focused organizations.
NVIDIA Inception supports startups during key phases of product development, prototyping, and deployment. Members receive tailored benefits, including credits for NVIDIA’s Deep Learning Institute, preferred pricing on NVIDIA hardware and software, and ongoing technical guidance—providing essential tools to drive growth and innovation.
